HITE Hedge Asset Management’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-798	Closed	-$267K	–	96
2022 Q1	$267K	Sell	798 -227	-22%	-$76K	0.03%	138
2021 Q4	$333K	Hold	1,025	–	–	0.04%	141
2021 Q3	$498K	Hold	1,025	–	–	0.06%	126
2021 Q2	$476K	Buy	+1,025	New	+$476K	0.07%	124